NASDAQ · IPEX
Financial Services · Asset Management
$8.58
Up+$0.48 (+5.93%)
Updated Sep 15, 2026, 11:18 AM
SID Score
2.4/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 18 trading sessions · Daily adjusted prices
IPEX closed at $8.58 after 18 trading sessions, down 18.29% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 14, 2026 | $8.72 | $9.025 | $8.51 | $8.58 | 13.47K |
| Sep 11, 2026 | $8.50 | $9.2799 | $8.10 | $8.10 | 75.96K |
| Sep 10, 2026 | $8.69 | $9.50 | $8.18 | $8.58 | 236.88K |
| Sep 9, 2026 | $8.81 | $9.29 | $8.7301 | $9.18 | 22.18K |
| Sep 8, 2026 | $7.98 | $8.49 | $7.81 | $8.49 | 37.13K |
| Sep 4, 2026 | $10.84 | $11.15 | $6.00 | $7.75 | 322.62K |
| Sep 3, 2026 | $11.33 | $11.905 | $10.87 | $10.92 | 17.31K |
| Sep 2, 2026 | $9.55 | $11.00 | $9.5001 | $11.00 | 18.33K |
| Sep 1, 2026 | $10.40 | $10.60 | $10.40 | $10.60 | 1.51K |
| Aug 31, 2026 | $10.60 | $10.69 | $10.59 | $10.60 | 24.79K |
| Aug 28, 2026 | $10.70 | $10.70 | $10.60 | $10.60 | 56.51K |
| Aug 27, 2026 | $10.60 | $10.69 | $10.60 | $10.69 | 4.28K |
| Aug 26, 2026 | $10.60 | $10.60 | $10.60 | $10.60 | 1.53K |
| Aug 25, 2026 | $10.55 | $10.55 | $10.50 | $10.55 | 7.06K |
| Aug 24, 2026 | $10.53 | $10.55 | $10.53 | $10.55 | 1.51K |
| Aug 21, 2026 | $10.5446 | $10.5446 | $10.53 | $10.53 | 608 |
| Aug 19, 2026 | $10.54 | $10.54 | $10.535 | $10.535 | 679 |
| Aug 17, 2026 | $10.59 | $10.59 | $10.50 | $10.50 | 1.51K |
The latest Smart Investors Daily articles mentioning IPEX.
IPEX research
Company profile and research snapshot.
Inflection Point Acquisition Corp V is a blank check company.
Consensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 4, 2026 | Benchmark | Buy | — |
No generated briefing is available yet.
Benzinga · Aug 11, 2026
nflection Point Acquisition Corp. V (NASDAQ:IPEX), a special purpose acquisition company ("SPAC") sponsored by Inflection Point Fund I LP, and GOWell Technology Limited ("GOWell") today announced that
Benzinga · Aug 4, 2026
Benchmark analyst Subash Chandra initiates coverage on Inflection Point Acq (NASDAQ:IPEX) with a Buy rating and announces Price Target of $14.
Benzinga · Mar 26, 2026
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning IPEX.
